Treatment of mitral regurgitation

Monaldi Arch Chest Dis. 2017 Jul 18;87(2):854. doi: 10.4081/monaldi.2017.854.

Abstract

In the elderly mitral regurgitation is very frequent and surgical correction of mitral regurgitation (MR) has often a high operative risk, consequently, over the years, different percutaneous transcatheter techniques have been developed as a valid alternative to surgery. The edge-to-edge repair with the MitraClip device has gained a wide clinical application, supported by several studies, both randomize trials and registries. It is indicated in functional MR as in degenerative MR. The outcome is usually positive, resulting in a reduction of the regurgitation to grade 1+ or 2+ and an improvement in the functional class to I or II reducing hospitalizations. Its cost-effectiveness too is supported by some studies.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Cost-Benefit Analysis
  • Heart Valve Prosthesis Implantation / methods*
  • Hospitalization / economics*
  • Hospitalization / statistics & numerical data
  • Humans
  • Mitral Valve / pathology
  • Mitral Valve / surgery*
  • Mitral Valve Insufficiency / physiopathology
  • Mitral Valve Insufficiency / surgery*
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Severity of Illness Index
  • Treatment Outcome